Sotax automated HPLC-dissolution platform
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is seeking a Sotax automated HPLC-dissolution platform to enhance lab testing capabilities for generic drugs. This acquisition serves as a critical replacement for the existing Waters Alliance dissolution platform and USP 2 apparatus, which are over 15 years old and no longer supported by the vendor, leading to significant challenges in parts procurement. This equipment is essential for OPQR laboratory operations to conduct dissolution studies that support OPQ mission objectives, research goals, and GDUFA program needs. By ensuring continued analytical capability for drug product testing, the new platform will maintain the operational integrity of the laboratory's testing processes.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Prepare for this forecast
Research this forecast and prepare for the solicitation
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
